Conjunctivitis in COVID-19 patients: frequency and clinical presentation

• DOI: 10.1007/s00417-020-04916-0
• Publication Date: 2020-08-29T11:02:42Z
• Authors: Noemi Güemes-Vill...; Barbara Burgos-Bl...; Julián García-Feijoó; Federico Sáenz-Fr...; Pedro Arriola-Vil...; Jose María Martin...; Jose Manuel Benít...; María Herrera de ...
• Keywords: Cross-sectional study

The purpose of this study was to evaluate the frequency and clinical presentation conjunctivitis in hospitalized patients with COVID-19.A cross-sectional conducted at Hospital Clinico San Carlos Madrid, Spain. A total 301 subjects from COVID admission unit laboratory-confirmed SARS-CoV-2 infection were included. presence characteristics evaluated. Laboratory, radiological, results without stratified by sex analyzed.Of included, 180 (59.8%) male median age 72 years (IQ 59-82). Overall, 35 (11.6%) diagnosed acute conjunctivitis. We found no relationship between COVID-19 severity score (P = 0.17). However, more frequent males moderate women classified as clinically mild. natural history disease seems be a rapid self-limited that improves treatment does not affect visual acuity nor associate short-term complications.Approximately, 1 out 10 non-critical presents during disease. Compared other viral conjunctivitis, we distinctive findings could guide defining differentiating patients.20/336_E_COVID.